Does phosphoinositide hydrolysis mediate ‘inhibitory’ as well as ‘excitatory’ muscarinic responses?
Joan Heller Brown1 and Susan Brown Masters2 Division of Pharmacology, Department of Medicine, University of California, San Diego, La Jolla, CA 92093 USA 1 Joan Heller Brown is an Assistant Professor of Medicine in the Division of Pharmacology, Department of Medicine, University of California, San Diego. She received her Ph.D. in Pharmacology from Albert Einstein College of Medicine for studies on the dopamine-sensitive adenylate cyclase of retina. She was a postdoctoral fellow in the Department of Pharmacology at the University of Colorado and a Research Associate at the University of California, San Diego. 2 Susan Brown Masters recently received her Ph.D. in Physiology and Pharmacology from the University of California, San Diego. For her graduate work, she studied the relationship between muscarinic stimulation of phosphoinositide metabolism and other molecular responses. She is presently a postdoctoral fellow in the Department of Pharmacology at the University of California, San Fr
